Literature DB >> 25735637

Sex and laterality differences in parkinsonian impairment and transcranial ultrasound in never-treated schizophrenics and their first degree relatives in an Andean population.

Danielle Kamis1, Lee Stratton1, María Calvó2, Eduardo Padilla2, Néstor Florenzano3, Gonzalo Guerrero4, Beatriz Molina Rangeon4, Juan Molina1, Gabriel A de Erausquin5.   

Abstract

We tested the hypothesis that loss of substantia nigra neurons in subjects at risk of schizophrenia (1), as reflected by midbrain hyperechogenicity (2) and parkinsonian motor impairment (3), is asymmetric and influenced by sex. We evaluated 62 subjects with never-treated chronic schizophrenia, 80 of their adult, unaffected first degree relatives and 62 healthy controls (matched by sex and age to the cases), part of an Andean population of Northern Argentina. Parkinsonism was scored blindly using UPDRS-3 (Unified Parkinson's Disease Rating Scale) on videotaped exams by 2 independent raters. Transcranial ultrasound was performed by an expert sonographist blind to subject condition with a 2.5 MHz transducer through a temporal bone window. Quantification of echogenic area was carried out on saved images by a different evaluator. We found a significant difference in parkinsonian motor impairment between patients, their relatives as well as controls. All three groups showed worse parkinsonism on the left side than the right, corresponding with increased echogenicity on the right substantia nigra compared with the left. Females had significantly more right echogenicity than males, and patients and unaffected relatives were significantly more echogenic than controls on that side. On the left, only female patients had significant echogenicity. Our data supports the notion that unaffected relatives of schizophrenic subjects have increased parkinsonism and concomitant brainstem abnormalities which may represent a vulnerability to the disease. Both motor and brainstem abnormalities are asymmetric and influenced by sex.
Copyright © 2015 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Dimorphism; Laterality; Parkinsonism; Schizophrenia; Transcranial ultrasound

Mesh:

Year:  2015        PMID: 25735637      PMCID: PMC4409537          DOI: 10.1016/j.schres.2015.01.035

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  45 in total

Review 1.  A review and Bayesian meta-analysis of clinical efficacy and adverse effects of 4 atypical neuroleptic drugs compared with haloperidol and placebo.

Authors:  Marianne Klemp; Ingunn Fride Tvete; Tor Skomedal; Jørund Gaasemyr; Bent Natvig; Ivar Aursnes
Journal:  J Clin Psychopharmacol       Date:  2011-12       Impact factor: 3.153

2.  Mirror movements in Parkinson's disease: effect of dopaminergic drugs.

Authors:  A J Espay; F Morgante; C Gunraj; R Chen; A E Lang
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-10       Impact factor: 10.154

3.  Synaptic contacts in schizophrenia: studies using immunocytochemical identification of dopaminergic neurons.

Authors:  N S Kolomeets; N A Uranova
Journal:  Neurosci Behav Physiol       Date:  1999 Mar-Apr

Review 4.  Hyperechogenicity of the substantia nigra: pitfalls in assessment and specificity for Parkinson's disease.

Authors:  Daniela Berg
Journal:  J Neural Transm (Vienna)       Date:  2010-09-10       Impact factor: 3.575

5.  Schizophrenia is associated with elevated amphetamine-induced synaptic dopamine concentrations: evidence from a novel positron emission tomography method.

Authors:  A Breier; T P Su; R Saunders; R E Carson; B S Kolachana; A de Bartolomeis; D R Weinberger; N Weisenfeld; A K Malhotra; W C Eckelman; D Pickar
Journal:  Proc Natl Acad Sci U S A       Date:  1997-03-18       Impact factor: 11.205

6.  Incidence and correlates of acute extrapyramidal symptoms in first episode of schizophrenia.

Authors:  M H Chakos; D I Mayerhoff; A D Loebel; J M Alvir; J A Lieberman
Journal:  Psychopharmacol Bull       Date:  1992

7.  The global costs of schizophrenia.

Authors:  Martin Knapp; Roshni Mangalore; Judit Simon
Journal:  Schizophr Bull       Date:  2004       Impact factor: 9.306

8.  Susceptibility to neuroleptic-induced parkinsonism--age and increased substantia nigra echogenicity as putative risk factors.

Authors:  Burkhard Emanuel Jabs; Andreas Joachim Bartsch; Bruno Pfuhlmann
Journal:  Eur Psychiatry       Date:  2003-06       Impact factor: 5.361

Review 9.  Neuroprotective actions of sex steroids in Parkinson's disease.

Authors:  Mélanie Bourque; Dean E Dluzen; Thérèse Di Paolo
Journal:  Front Neuroendocrinol       Date:  2009-05-03       Impact factor: 8.606

10.  Effects of two commonly found strains of influenza A virus on developing dopaminergic neurons, in relation to the pathophysiology of schizophrenia.

Authors:  Fernando Landreau; Pablo Galeano; Laura R Caltana; Luis Masciotra; Agustín Chertcoff; A Pontoriero; Elsa Baumeister; Marcela Amoroso; Herminia A Brusco; Mónica I Tous; Vilma L Savy; María del Rosario Lores Arnaiz; Gabriel A de Erausquin
Journal:  PLoS One       Date:  2012-12-10       Impact factor: 3.240

View more
  4 in total

1.  Detection, Assessment, and Management of Schizophrenia in an Andean Population of South America: Parkinsonism Testing and Transcranial Ultrasound as Preventive Tools.

Authors:  Mara Balda; Maria Calvó; Eduardo Padilla; Gonzalo Guerrero; Juan Molina; Nestor V Florenzano; Danielle Kamis; Javier I Escobar; C Robert Cloninger; Gabriel de Erausquin
Journal:  Focus (Am Psychiatr Publ)       Date:  2015

2.  Psychomotor Slowing in Schizophrenia: Implications for Endophenotype and Biomarker Development.

Authors:  K Juston Osborne; Sebastian Walther; Stewart A Shankman; Vijay A Mittal
Journal:  Biomark Neuropsychiatry       Date:  2020-05-12

3.  Prediction of Neurocognitive Deficits by Parkinsonian Motor Impairment in Schizophrenia: A Study in Neuroleptic-Naïve Subjects, Unaffected First-Degree Relatives and Healthy Controls From an Indigenous Population.

Authors:  Juan L Molina; Gabriela González Alemán; Néstor Florenzano; Eduardo Padilla; María Calvó; Gonzalo Guerrero; Danielle Kamis; Lee Stratton; Juan Toranzo; Beatriz Molina Rangeon; Helena Hernández Cuervo; Mercedes Bourdieu; Manuel Sedó; Sergio Strejilevich; Claude Robert Cloninger; Javier I Escobar; Gabriel A de Erausquin
Journal:  Schizophr Bull       Date:  2016-03-18       Impact factor: 9.306

4.  Parkinsonian motor impairment predicts personality domains related to genetic risk and treatment outcomes in schizophrenia.

Authors:  Juan L Molina; María Calvó; Eduardo Padilla; Mara Balda; Gabriela González Alemán; Néstor V Florenzano; Gonzalo Guerrero; Danielle Kamis; Beatriz Molina Rangeon; Mercedes Bourdieu; Sergio A Strejilevich; Horacio A Conesa; Javier I Escobar; Igor Zwir; C Robert Cloninger; Gabriel A de Erausquin
Journal:  NPJ Schizophr       Date:  2017-01-11
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.